MedTrace Logo

The Effects of Nitric Oxide for Inhalation in Right Ventricular Infarction Patients

NCT00782652 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2016-09-09

No results posted yet for this study

Summary

This study is designed to better understand the effects of nitric oxide, a gas for inhalation, on patients with right ventricular infarction.

Conditions

  • Right Ventricular Infarction

Interventions

DRUG

inhaled nitric oxide

Continuous delivery at either 40 or 80 ppm for a duration of up to 14 days

DRUG

nitrogen gas

Continuous delivery at either 40 or 80 ppm for a duration of up to 14 days

Sponsors & Collaborators

  • Mallinckrodt

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2007-02-28
Completion
2007-02-28

Countries

  • United States
  • Belgium
  • Canada
  • Poland
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00782652 on ClinicalTrials.gov